Company Overview

Irwin Naturals, Inc. (OTC: IWINQ) is a U.S.-based health and wellness company historically focused on the development, marketing, and distribution of nutraceutical and dietary supplement products. The company operates in the consumer health industry, with products spanning categories such as cognitive health, sexual wellness, energy support, weight management, joint health, and immune support. Its core revenue drivers have traditionally come from branded vitamin and supplement products sold through retail, e-commerce, and distribution channels across North America. In recent years, the company also pursued expansion into behavioral health and psychedelic-assisted therapy through healthcare clinic acquisitions and related investments.

The company traces its origins to the Irwin Naturals supplement brand established in the 1990s by Klee Irwin. Irwin Naturals became known for its “liquid soft-gel” delivery format and broad retail distribution in mass-market and pharmacy channels. Following its public market listing, the company sought to diversify beyond supplements into mental health services and emerging therapeutic sectors. Public disclosures and market reporting indicate that the company experienced financial distress and restructuring challenges, including bankruptcy-related developments associated with the “Q” ticker designation. Certain operational and financial details remain limited due to evolving public filings and restructuring proceedings.

Business Operations

Irwin Naturals historically generated revenue primarily through its Nutraceuticals business, which included branded vitamins, supplements, and wellness formulations distributed through retailers, online platforms, and wholesale channels. The company also expanded into healthcare services through behavioral health clinic operations tied to psychedelic-assisted therapy initiatives. Public filings and investor materials identified strategic interests in ketamine-assisted treatment clinics and related healthcare infrastructure. The company’s operations included both consumer packaged goods and healthcare service components, though the relative contribution of each segment shifted over time.

The company’s operational footprint was concentrated in the United States, with supplement distribution extending into international markets through retail and distribution relationships. Irwin Naturals controlled intellectual property tied to formulations, branding, and product delivery systems associated with its supplement portfolio. Reported subsidiaries and affiliated operations included entities connected to healthcare clinics and wellness services. The company also pursued partnerships and acquisitions intended to support expansion into behavioral health treatment and emerging therapeutic categories. Some details regarding the current status of these operations are difficult to verify consistently across recent public disclosures.

Strategic Position & Investments

Irwin Naturals positioned itself as a wellness company seeking to bridge traditional consumer supplements with mental health and alternative therapeutic services. Its strategic direction emphasized diversification beyond legacy nutraceutical products into behavioral healthcare infrastructure and psychedelic-related treatment markets. This included investments in clinic networks and healthcare delivery platforms intended to capitalize on growing interest in mental health treatment accessibility and novel therapeutic approaches.

The company disclosed acquisitions and investments involving behavioral health clinics and ketamine treatment operations, including entities associated with psychedelic-assisted therapy expansion strategies. Public statements and filings also referenced efforts to develop integrated wellness and mental health ecosystems combining supplements, healthcare services, and emerging therapeutic technologies. However, ongoing financial restructuring and bankruptcy-related developments created uncertainty around the execution and continuity of several initiatives. Data inconclusive based on available public sources regarding the full operational status of certain acquired entities and long-term investment programs.

Geographic Footprint

Irwin Naturals is headquartered in the United States, with historical operational concentration in California and broader North American retail distribution networks. Its supplement products were sold through major retail chains, pharmacies, and online channels across the United States and parts of Canada. The company’s healthcare and clinic-related initiatives were also primarily U.S.-focused.

The company maintained market exposure across multiple consumer wellness categories with some international brand recognition through distribution relationships outside the United States. Publicly available information indicates that its direct operational infrastructure remained predominantly domestic, while international reach was achieved mainly through product distribution arrangements rather than large-scale foreign operating subsidiaries. Data inconclusive based on available public sources regarding the current extent of international operations following restructuring activities.

Leadership & Governance

Irwin Naturals was founded by Klee Irwin, who played a central role in shaping the company’s branding, wellness positioning, and expansion strategy into behavioral health and psychedelic-related services. Leadership messaging in public communications emphasized innovation in health and wellness, consumer accessibility, and integration between preventive wellness products and mental healthcare services. Governance and executive structure evolved alongside the company’s strategic diversification and restructuring efforts.

Key executives and leadership figures identified in public filings and company disclosures include:

• Klee Irwin – Founder and former Chairman
• Bryan H. Austin – Chief Executive Officer
• David C. Martin – Chief Financial Officer
• Kimberly L. Irwin – Executive leadership and governance roles reported in company disclosures

Public records, including SEC filings, indicate that leadership priorities included expanding healthcare service capabilities, pursuing acquisitions in behavioral health, and leveraging the established Irwin Naturals consumer brand to support broader wellness initiatives. Certain executive roles and governance structures may have changed during restructuring proceedings, and some information remains subject to ongoing public filing updates.